MicroCNX connectors are a critically important option for a range of bioprocessing, cell therapy and gene therapy workflows,.”Until now, cumbersome tube welding has been the only way to make sterile closed connections of very small-bore tubing. The MicroCNX connector represents a huge innovation for the industry.
Spectrum Plastics Group, a global solutions provider for development through scaled manufacturing of critical polymer-based components and devices for medical and other demanding markets, is excited to announce a significant renovation and cleanroom expansion project at its Minneapolis, MN facility.
Proposed acquisition of Trillium strengthens Pfizer’s category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for hematological malignancies
Platforms for kidney exchanges such as the National Kidney Registry and the Alliance for Paired Donation provide a lifeline for people on the waiting list by expanding the pool of potential donors by matching potential recipients with living donors they’ve never met.
Gerresheimer will acquire the Swiss technology company Sensile Medical and thereby significantly expand its business offerings. For the Sensile Medical business, this will open up new opportunities and synergies with existing and potential new customers.
The research involved kinesin proteins: tiny, protein-based motors that interact with microtubules inside cells. The motors convert chemical energy into mechanical energy to generate the directional movements and forces necessary to sustain life. Microtubules are microscopic tubular structures that have two distinct ends: a fast-growing plus end and a slow-growing minus ends. Microtubules help make up a cell’s skeleton.
Today PPC Flexible Packaging announced it has completed the first phase of a greater than $2 million facilities and equipment investment aimed at expanding and further upgrading production capacities for its Precision Clean™ cleanroom packaging business. The company purchased its Buffalo Grove based business as Fisher Container Corporation in February 2017.
“It was as long ago as 1991 when we discovered that, in many elderly people infected with HSV1, the virus is present also in the brain, and then in 1997 that it confers a strong risk of Alzheimer’s disease in the brain of people who have a specific genetic factor.”
In the maze of our brains, there are various pathways by which neural signals travel. These pathways can go awry in patients with neurological and psychiatric diseases and disorders, including epilepsy, Parkinson’s, and obsessive-compulsive disorder. Researchers have developed new therapeutic strategies to more precisely target neural pathways involved in these conditions, but they often require surgery.
Scientists from The University of Texas at Austin took an important step toward safer gene editing cures for life-threatening disorders, from cancer to HIV to Huntington’s disease, by developing a technique that can spot editing mistakes a popular tool known as CRISPR makes to an individual’s genome. The research appears today in the journal Cell.
By developing nanoparticle “backpacks” that hold immune-stimulating drugs, and attaching them directly to T cells, the MIT engineers showed in a study of mice that they could enhance those T cells’ activity without harmful side effects. In more than half of the treated animals, tumors disappeared completely.
Biotechnology Innovation Platform Launch expected to become a national-level technology startup incubator. It aims to host at least 50 spinoff companies and commercialize the results of at least 10 HKU research projects within five years. The platform will focus on key areas including cancer treatment, medical devices and infectious disease treatment.